- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17:54 | Arcus Biosciences stock rating held at Neutral by BofA on rival trial data | ||
| 17:54 | Jefferies reiterates Churchill Downs stock rating on Preakness deal | ||
| 17:42 | Revolution Medicines to present phase 3 pancreatic cancer data at ASCO | ||
| 17:42 | Galliford Try wins £750m affordable homes framework contract | ||
| 17:42 | Raymond James raises Altius Minerals stock price target on revenue growth | ||
| 17:42 | William Blair reiterates Eupraxia stock rating on trial data | ||
| 17:42 | BofA raises PG&E stock price target to $23 on capital investment | ||
| 17:42 | Blue Bird stock rating reiterated at Buy by Craig-Hallum on strong positioning | ||
| 17:42 | Magnite stock rating maintained at Buy by Craig-Hallum amid exits | ||
| 17:42 | BofA raises Synchrony Financial price target on volume trends | ||
| 17:18 | Kemper completes sale of captive agent business to Confie | ||
| 17:18 | Klarna resell feature sees 75% growth in listings over 13 months | ||
| 17:18 | Prosus non-executive director Steve Pacak passes away | ||
| 17:18 | Macquarie raises Rio Tinto stock price target on aluminum strength | ||
| 17:18 | Telsey reiterates Tractor Supply stock rating after soft quarter | ||
| 16:54 | Black Diamond to present silevertinib data at ASCO meeting | ||
| 16:54 | Karyopharm's myelofibrosis trial selected for ASCO presentation | ||
| 16:54 | Regeneron submits U.S. application for gMG treatment cemdisiran | ||
| 16:54 | Immunome's desmoid tumor trial data selected for ASCO presentation | ||
| 16:54 | RBC Capital reiterates Westlake Chemical stock rating on new CFO | ||
| 16:54 | RBC Capital maintains Shopify stock rating on strong e-commerce data | ||
| 16:54 | Mizuho raises GE Vernova stock price target on data center demand | ||
| 16:54 | Jefferies raises FirstEnergy stock price target on regulatory outlook | ||
| 16:54 | UBS reiterates Buy on Block stock, $90 target on design focus | ||
| 16:54 | RBC Capital reiterates Exelixis stock rating on competitive position |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.